glp-1 osteoporosis Use Associated with Lower Risk in Adults with Type 2 Diabetes but Higher Risk in Adults Without Diabetes Treatment of Diabetes and Osteoporosis—A

A new analysis presented at the American Academy of Orthopaedic Surgeons annual meeting in 2026 suggests that GLP-1 drugs may be linked to a higher risk of osteoporosis and gout in some patients

Spiekerkoetter, U., Lindner, M., Santer, R., Grotzke, M., Baumgartner, M

111 ReboucheC

The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases

If your interest is specifically the longevity matchup between a copper peptide and NAD+, read our honest side by side comparison of GHK-Cu and NAD+ as longevity tools, covering how each one works and which specific goals each is better suited to support